Media formulation using statistical methodology to enhance α-amylase production for green synthesis of Au-NPs by Bacillus subtilis VSP4 under solid-state fermentation.
IF 4.8 3区 工程技术Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Vimalkumar S Prajapati, Vaibhavkumar N Mehta, Swati K Patel
{"title":"Media formulation using statistical methodology to enhance α-amylase production for green synthesis of Au-NPs by <i>Bacillus subtilis</i> VSP4 under solid-state fermentation.","authors":"Vimalkumar S Prajapati, Vaibhavkumar N Mehta, Swati K Patel","doi":"10.3389/fbioe.2025.1569902","DOIUrl":null,"url":null,"abstract":"<p><p>In recent years, gold nanoparticles (Au-NPs) have garnered popularity for their remarkable and promising applications in various areas. Here, we report the synthesis of Au-NPs using extracellular amylase produced by <i>Bacillus subtilis</i> VSP4 under solid-state fermentation (SSF) through the reduction of AuCl<sub>4</sub> with retention of enzymatic activity in the complex. Accordingly, <i>B. subtilis</i> VSP4 was exploited to enhance α-amylase production under SSF using the Plackett-Burman design, followed by the central composite design (CCD) of response surface methodology (RSM). According to our analysis, the most significant components in the medium are starch, yeast extract, and CaCl<sub>2</sub> (significance >95%, ANOVA), which prominently enhance enzyme production. The optimum levels of these three selected variables were evaluated using CCD-RSM (20 runs), and it was confirmed that 0.05 g of starch, 0.1 g of yeast extract, and 5 mM of CaCl<sub>2</sub> per 5 g of wheat bran under SSF produced the maximum α-amylase yield (169.72 U/gds). The <i>F</i>-value of the quadratic model (18.36) implies that the model is significant, while the <i>F</i>-value of the lack of fit (3.17) indicates that the lack of fit is not significant, meaning that the model has good fit. The coefficient of variance was found to be 0.369, which denotes that the experiments performed herein are reliable (R<sup>2</sup> = 0.94) (multiple correlation coefficient), and the standard deviation for the quadratic model was found to be 4.72. We also performed separate validation experiments to confirm the adequacy of the quadratic model. The present work highlights α-amylase production by <i>B. subtilis</i> VSP4 under SSF, which was prominently enhanced by adopting a statistical experimental design, leading to the formation of Au-NPs of average size 5.17 ± 0.85 nm showing a surface plasmon resonance peak at 528 nm.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1569902"},"PeriodicalIF":4.8000,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12170647/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1569902","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
In recent years, gold nanoparticles (Au-NPs) have garnered popularity for their remarkable and promising applications in various areas. Here, we report the synthesis of Au-NPs using extracellular amylase produced by Bacillus subtilis VSP4 under solid-state fermentation (SSF) through the reduction of AuCl4 with retention of enzymatic activity in the complex. Accordingly, B. subtilis VSP4 was exploited to enhance α-amylase production under SSF using the Plackett-Burman design, followed by the central composite design (CCD) of response surface methodology (RSM). According to our analysis, the most significant components in the medium are starch, yeast extract, and CaCl2 (significance >95%, ANOVA), which prominently enhance enzyme production. The optimum levels of these three selected variables were evaluated using CCD-RSM (20 runs), and it was confirmed that 0.05 g of starch, 0.1 g of yeast extract, and 5 mM of CaCl2 per 5 g of wheat bran under SSF produced the maximum α-amylase yield (169.72 U/gds). The F-value of the quadratic model (18.36) implies that the model is significant, while the F-value of the lack of fit (3.17) indicates that the lack of fit is not significant, meaning that the model has good fit. The coefficient of variance was found to be 0.369, which denotes that the experiments performed herein are reliable (R2 = 0.94) (multiple correlation coefficient), and the standard deviation for the quadratic model was found to be 4.72. We also performed separate validation experiments to confirm the adequacy of the quadratic model. The present work highlights α-amylase production by B. subtilis VSP4 under SSF, which was prominently enhanced by adopting a statistical experimental design, leading to the formation of Au-NPs of average size 5.17 ± 0.85 nm showing a surface plasmon resonance peak at 528 nm.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.